Better Buy: Gilead Sciences, Inc. vs. Amgen

Better Buy: Gilead Sciences, Inc. vs. Amgen

Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their product portfolios at the moment.

This is therefore an opportune time to consider which of these top biotech stocks is the better long-term buy right now. So let's dig in to reveal which of these biotech giants is more deserving of your hard-earned capital.   

Image source: Getty Images.

Continue reading

Source: Fool.com